Upgrade to SI Premium - Free Trial

Viking Therapeutics (VKTX) Misses Q1 EPS by 35c

April 29, 2026 4:16 PM

Viking Therapeutics (NASDAQ: VKTX) reported Q1 EPS of ($1.37), $0.35 worse than the analyst estimate of ($1.02).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

Categories

Earnings